Sambrinvest

Active

Website LinkedIn X

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 5, 2026	Vertical Compute	$43.0M Seed Extension	William Zeng	Bpifrance, Drysdale, Thomas Turelier, Vincent Hebbelynck, imec, Tom Vanhoutte, Invest.BW, Kima Ventures, Noshaq, Vector Gestion, VLAIO, Wallonie Entreprendre, Guilhem De Vregille
Jan 8, 2026	Enodia Therapeutics	$24.2M Seed	Florian Denis, Olivier Martinez	Valentin TONNEL, Daniel Sobral, InvestSud, MACSF, Mission BioCapital
Sep 4, 2023	cikisi	$2.9M Pre-Series A	Marc Mommaerts	Pierre Hermant, InvestSud
Sep 1, 2023	AbolerIS Pharma	$29.0M Series A	Caixa Capital	BioVentures Investors, Newton Biocapital, SFPI-FPIM, Sound Bioventures, Sudinvest, Turenne Capital, Wallonie Entreprendre
Jun 7, 2023	Santero Therapeutics	$8.6M Series A	Philippe De Backer, Newton Biocapital	SFPI-FPIM, Wallonie Entreprendre
Feb 1, 2022	Aerospacelab	$45.0M Series B	Airbus Ventures, XAnge	360 Capital Partners, Didier Valet, Rand Hindi, BNP Paribas Private Equity, Nicolas Dhaene
Dec 6, 2021	PDC*line Pharma	$26.2M Grant / Series B	Sangwoo Lee	Alpha Holdings, Brain Asset Management, Hansongneotech, Noshaq, Fontaine François, Smart Korea UTC Bio-Healthcare Venture Fund, SRIW, Walloon Region
Sep 30, 2021	EsoBiotec	$7.0M Pre-Series A	—	Helena Pozios, Franssen Christina, Michel Briejer, Walloon Region
Jun 1, 2021	Amyl Therapeutics	$10.0M Series A	Noshaq	Earlybird Venture Capital, Valerie Calenda
May 24, 2021	ExeVir Bio	$50.0M Series A	Philippe Monteyne	Belgian family offices, Noshaq, Stef HEYLEN, MD, Caroline THIELEN, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet, Joël Henneghien
Feb 14, 2020	OncoDNA	$20.6M Series B	Robert Schier, Guy Geldhof	CPH Bank, Inventures, Fontaine François, Sofinim, SRIW
Jan 22, 2020	PDC*line Pharma	$15.4M Series B	—	Financière Spin-off Luxembourgeoise, Sangwoo Lee, Noshaq, SFPI-FPIM, Shinhan-Cognitive Start-up Fund, UTC 2019 BIOVENTUREFUND
May 17, 2019	Cognivia	$4.5M Series B	—	Jean-Pierre Delwart, Jean Stephenne, Innovation Fund
Feb 1, 2019	Sortlist	$2.0M Series A	—	Francois Van Uffelen, Mike Vandenhooft, Olivier Mertens
Sep 26, 2018	Minoryx Therapeutics	$25.1M Series B	Philippe Monteyne	Caixa Capital Risc, Chiesi Ventures, HealthEquity, Idinvest Partners, Kurma Partners, Roche, SFPI, Gery Lefebvre, Ysios Capital
Nov 17, 2017	Ncardia	$12.4M Series B	Marc Foidart	InnovationQuarter, SFPI-FPIM, SRIW, Vesalius Biocapital
Apr 1, 2017	Ncardia	$2.7M Other Equity	—	SFPI-FPIM
Sep 4, 2016	OncoDNA	$8.6M Other Equity	—	Crown Predator Holdings, Inventures, Invest4OncoDNA, IPG/bio.be, Sofinim, SRIW, Vinsovier
Jan 28, 2013	Bone Therapeutics	$10.4M Grant / Series D	—	BAMS Angel Fund, Life Sciences Research Partners, Nausicaa Ventures, SRIW
Mar 28, 2012	Promethera Biosciences	$31.4M Debt / Series B	—	ATMI, Boehringer Ingelheim, Financière Spin-off Luxembourgeoise, Life Sciences Research Partners, Mitsui & Co. Global Investment, Nivelinvest, Shire, Sopartec, SRIW, Vesalius Biocapital, VIVES Louvain Technology Fund, Walloon Region

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at Sambrinvest.

Anne Prignon

Managing Director

Leadership Team

Key people at Sambrinvest.

Anne Prignon

Managing Director